Humana Publishes Q3 2026 Earnings Call Transcript
Bitget2026/11/09 04:15- Humana raised its 2026 adjusted earnings outlook to at least $9.50 per share from at least $9, supported by favorable costs.
- CEO James A. Rechtin, CFO Celeste Mellet and investor relations chief Lisa Stoner attended the November 6 third-quarter earnings call with analysts.
- Management expects membership growth in 2027, with pricing driving material individual Medicare Advantage margin improvement despite continued Star Ratings pressure.
- Medical cost trends are projected at 8%–9% next year, versus 7%–8% this year, reflecting higher prescription drug costs.
- Exceptional Star Ratings should provide a one-time 2028 earnings benefit above targets, partly funding investments, with some flowing through to shareholders.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ-IIFL Finance rallies to a two-month high, boosted by Blackstone deal
The “outlier” in the AI capital expenditure frenzy: Apple (AAPL.US) keeps spending flat, accounting for less than 5% of sales
Apple continues to stand out among major tech peers, largely avoiding the aggressive wave of capital expenditure associated with artificial intelligence (AI) infrastructure.
Youth Employment Declines for 48 Consecutive Months: Behind the Semiconductor Boom, Young South Koreans Are Being Left Behind by the Times
In South Korea, the unemployment rate in October fell to a three-year low of 2.5%. However, the number of employed people decreased by 50,000, youth employment has declined for 48 consecutive months, and domestic demand remains weak.
Crypto prices
More
